We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Chong Kun Dang Holdings is a holding company that controls numerous subsidiaries, including Chong Kun Dang, which specializes in the manufacturing and sales of pharmaceuticals; Chong Kun Dang Bio, which produces biopharmaceuticals and active pharmaceutical ingredients; and Kyongbo Pharmaceutical. Its main business areas include pharmaceuticals, biotechnology, and health functional foods. Through subsidiary management and investment, it operates businesses across the entire pharmaceutical and healthcare industry.
종근당홀딩스는 지주회사로서 의약품 제조 및 판매를 주력으로 하는 종근당, 바이오의약품 및 원료의약품을 생산하는 종근당바이오, 경보제약 등 다수의 자회사를 거느리고 있습니다. 주요 사업 영역은 의약품, 바이오, 건강기능식품 등으로, 자회사 관리 및 투자를 통해 제약 및 헬스케어 산업 전반에 걸쳐 사업을 영위하고 있습니다.